Nachrichten zur Cytosorbents Corp. Aktie

OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA

NASDAQ: CTSOGreg Young: Hello and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host,…

CTSO: CytoSorbents Reports 1st Quarter Financial and Operating Results

By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORT1st Quarter 2026 Financial ResultsOn May 13, 2026, CytoSorbents (NASDAQ: CTSO)…

CTSO: CytoSorbents Reports Strong 4th Quarter and Full Year 2025 Results

By Thomas Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORT2025 Financial Results & Business UpdateOn March 25, 2026, CytoSorbents (NASDAQ:…

CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross Margins

By Thomas Kerr, CFANASDAQ:CTSOREAD THE FULL CTSO RESEARCH REPORTPreliminary 2025 Financial Results & Business UpdateOn January 12, 2026, CytoSorbents (NASDAQ:CTSO)…

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

CytoSorbents regains compliance with Nasdaq minimum bid price requirement…

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"…

CytoSorbents Secures $20 Million Credit Facility

$20 million credit facility provides CytoSorbents with important non-dilutive capital to support its regulatory and commercialization objectives…

CytoSorbents reports regulatory approval of CytoSorb in Taiwan

…

dpa-AFX ProFeed